New Insulin Price Cap Could End Up Saving Payers Money in the Long Run
HR Digest
MARCH 24, 2023
By Mark Campbell, Senior Vice President of Clinical Solutions at RxBenefits , the employee benefits industry’s first technology-enabled pharmacy benefits optimizer (PBO) Diabetes has reached epidemic proportions. Reducing out-of-pocket cost-sharing for insulin does mean payers and insurers may be covering a greater share of the costs.
52 
Let's personalize your content